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Abstract
Background and Aims: Q fever is a bacterial zoonosis caused by infection with Coxiella burnetii. It is well established
that Q fever causes fetal loss in small ruminants. The suspicion has been raised that pregnant women may also experience
adverse pregnancy outcome when the infection is acquired or reactivated during pregnancy. The purpose of this
study was to assess the potential association between serologic markers of infection with C.burnetii and spontaneous
abortion.
Methods: A nested case-control study within the Danish National Birth Cohort, a cohort of 100,418 pregnancies recruited
from 1996–2002. Women were recruited in first trimester of pregnancy and followed prospectively. Median gestational age
at enrolment was 8 weeks (25 and 75 percentiles: 7 weeks; 10 weeks). During pregnancy, a blood sample was collected at
gestational week 6–12 and stored in a bio bank. For this study, a case sample of 218 pregnancies was drawn randomly
among the pregnancies in the cohort which ended with a miscarriage before 22 gestational weeks, and a reference group of
482 pregnancies was selected in a random fashion among all pregnancies in the cohort. From these pregnancies, serum
samples were screened for antibodies against C. burnetii in a commercial enzyme-linked immunosorbent assay (ELISA).
Samples that proved IgG or IgM antibody positive were subsequently confirmatory tested by an immunofluorescence (IFA)
test.
Results: Among cases, 11 (5%) were C. burnetii positive in ELISA of which one was confirmed in the IFA assay compared to
29 (6%) ELISA positive and 3 IFA confirmed in the random sample.
Conclusions: We found no evidence of a higher prevalence of C.burnetii antibodies in serum samples from women who later
miscarried and the present study does not indicate a major association between Q fever infection and spontaneous
abortion in humans. Very early first trimester abortions were, however, not included in the study.
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Introduction
Q fever, a zoonotic infection caused by Coxiella burnetii, has
previously been considered a rare, imported infection in Denmark,
but recent studies have found antibodies against C.burnetii in a large
percentage of Danish dairy herds and among individuals exposed
to livestock animals [1–3].
In cattle and small ruminants Q fever is known to cause
abortions, retained placenta, endometritis and infertility, and
placentas of infected animals contain a high number of organisms
[4,5]. The bacteria remain viable for months in the environment
and the most important route of transmission to humans is
inhalation of contaminated aerosols.
For otherwise healthy people, Q fever infection is often
asymptomatic or with a mild, flu-like course, but may also cause
severe pneumonia. Pregnant women, immunocompromised pa-
tients and patients with pre-existing cardiac valve or vascular
defects are at risk of a severe course of the infection [6,7], [8].
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31909The precise mechanisms by which the infection compromises
pregnancy are largely unknown, but adverse pregnancy outcome
has been reproduced in BALB/c mice in which infection followed
by repeated pregnancies resulted in spontaneous abortion and
perinatal death [9].
C. burnetii is an intracellular pathogen, but the cell types infected
by C.burnetii in humans are unknown. A recent study used a human
trophoblast cell line and found that C.burnetii infected and
replicated within trophoblastic cells but the bacteria seemed
unable to interfere with development of a normal pregnancy.
The study suggested that normal development of pregnancy may
be impaired by the cooperation of trophoblasts and placental
immune cells responsive to C.burnetii within the placental tissue [10].
Present evidence mainly originates from French case studies of
referred pregnant women in which infection resulted in sponta-
neous abortion, intrauterine growth retardation, oligohydramnion,
stillbirth and premature delivery in untreated pregnancies. One
series of 53 cases demonstrated obstetric complications in 81% of
Q fever positive cases not receiving long-term antibiotic treatment
[11]. Infection in pregnancy is often asymptomatic but may imply
an increased risk of chronic infection [8]. A risk of reactivation of a
past infection in subsequent pregnancies has been described and
infection in 1
st trimester may constitute a specific risk of
spontaneous abortion [11–13].
Due to the sparse literature on Q fever in pregnancy, unbiased
estimates of the risks of adverse pregnancy outcome among
infected women remain largely unknown, and even though Q
fever is endemic worldwide many obstetricians know little about
the infection. The incidence of Q fever among pregnant women
may therefore be underestimated [8].
The objective of the present study was to compare the
prevalence of antibodies to C.burnetii in a random sample of
pregnancies terminated by spontaneous abortion to the prevalence
in the background population.
Materials and Methods
Ethics statement
Women enrolled in the Danish National Birth Cohort gave both
verbal and written consent to participate. The women gave
permission to include interview information, blood samples and
health information from other registers in the Danish National
Birth Cohort. The study was approved by the Danish National
Birth Cohort, the Danish Data Protection Board, and the Danish
Regional Scientific Ethical Committee.
Participants
The study was based on interview data and blood samples from
the Danish National Birth Cohort (DNBC), which is a nationwide
cohort of 100,418 pregnant women and their offspring.
Enrolment in the DNBC took place between 1996 and 2002,
and the women were recruited in connection with the first
antenatal visit to the general practitioner. Gestational age at
enrolment was scheduled to be 10 weeks. The median gestational
week of enrolment was 8 weeks (25 and 75 percentiles: 7 weeks; 10
weeks), but some women were enrolled as early as in week 4 and as
late as gestational week 27.
The percentage of pregnancies that resulted in a spontaneous
abortion in the entire cohort was 4.7%. Foetal life table analysis
has estimated the proportion of spontaneous abortions from
gestational week 6 to be 11% in the DNBC [14].
Information on exposures before and during the early part of
pregnancy was collected by means of a computer assisted telephone
interview scheduled to take place in gestational week 12 or as soon
as possible thereafter. In case of fetal loss before this interview,
participants were offered a similar interview as soon as possible after
the fetal loss (interview forms available at www.bsmb.dk).
During pregnancy, two blood samples were collected; one
around gestational week 6–12, the second in gestational week 24.
A sample was also drawn from the umbilical chord.
The interviews were not performed if the women were not
reached within four phone calls, or did not wish to participate.
A more detailed description of the cohort can be found
elsewhere [15].
This study was designed as a nested case-control study. A
number of 200 pregnancies were randomly selected from the 4740
participants who experienced a miscarriage before 154 gestational
days (22 gestational weeks), and for whom a serum sample was
taken at the first antenatal visit at the GP and stored in a bio bank.
The case definition was miscarriage, defined as fetal loss before
154 days (22 weeks) after the self-reported first day of the last
menstrual period.
A base sample of 500 non-cases was randomly selected among
the 92500 participants with an existing first blood sample from
early pregnancy. A total of 18 of the pregnancies in the base
sample had spontaneous abortion as outcome and were conse-
quently reclassified as cases.
The random selection of cases and non-cases irrespectively of
participation in the scheduled interviews was chosen in order to
avoid selection bias.
Serology, specific antibody detection
C.burnetii expresses two antigens, phase II and phase I. In acute
Q fever, primarily antibodies against phase II are raised, and their
titer is higher than antibodies against phase I. As with most other
infections, IgM antibodies appear first.
In chronic forms of the disease, antibodies against phase I are
elevated.
When infected, phase II IgG and IgM antibodies are always
elevated, and, although declining, they may remain positive for
years. A large study from Australia and England found that phase II
IgG antibodies persisted after four and 12 years, respectively [16].
The diagnosis of Q fever relies upon serology. In order to
determine antibodies against C. burnetii, we chose a two-step
approach. First all samples were screened in a commercial
enzyme-linked immunosorbent assay (ELISA). Positive samples
from the ELISA were confirmed with an immunofluorescence
antibody test (IFA).
The commercial ELISA kit was purchased from Panbio
(Queensland, Australia) (cat. no. E-QFB01G and E-QFB01M)
and used according to the manufacturer’s instructions with one
minor modification. Due to low sample volume the samples were
not diluted as prescribed in the instructions but same dilution
factors were used.
Samples positive for either IgG or IgM antibodies in the ELISA
were confirmed with an IFA test from Focus Diagnostics
(ca.no. IF0200G and IF0200M). The test was performed accord-
ing to the instructions provided by the manufacturer, with the
following minor modification: due to low amount of sample
material, the diluted samples 1:10 from the ELISA were used to
further dilute the samples as described by the manufacturer. The
effect of the dilution in the Panbio buffer was tested prior to the
use on patient samples and did not show any influence on the
results (results not shown).
Also, the IFA cut-off suggested by the manufacturer was not
used; since the prevalence of the infection varies between
geographic areas, the cut-off suggested by the manufacturer is
not necessarily suited for any given area [17]. When reanalyzing
Q Fever and Risk of Spontaneous Abortion
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the Danish population as previously described [18].
In the analyses, the titres have been dichotomized in positive
and negative according to the Danish cut-off with the inconclusive
results categorized as negative.
A sample was considered positive when IgG titres phase I and II
against C. burnetii were 1:512 or higher or 1:1024 or higher,
respectively. For IgM a sample was considered positive with a titre
of IgM phase I of 1:128 or higher or IgM phase II of 1:256 or
higher [18].
In acute infection, antibodies against phase II antigens are
usually elevated, and a combination of rising antibodies against
IgG phase II and IgM usually indicates a present infection.
In a chronic infection, positive antibodies against IgG phase I
antigens indicates a possible persisting infection, keeping in mind
that diagnosing chronic Q fever requires more than elevated
antibodies, including symptoms and supplementary paraclinical
tests like PCR and culture of bone marrow.
When investigating the association between Q fever titres and
spontaneous abortion we consider IFA to be gold standard.
However, as other studies report their results based on ELISA
alone, we also report data on ELISA values to ensure
comparability with other studies.
All serological analyses were performed according to the
manufacturer’s instructions in a certified laboratory at Statens
Serum Institute, Denmark. Laboratory personnel were blinded for
case-status and samples were always analyzed in the same batch of
commercial kits.
Specimens
Blood samples from gestational week 6–12 were collected by the
general practitioners. Samples were mailed to the Statens Serum
Institut where they were stored at 230uC until assayed.
The final data set included 218 cases and 482 non-cases with
interview data covering reproductive history, age and smoking
status. For the co-variates, age was split into three categories,
women ,25 years, 25–35 and above 35 years. Reproductive
history was categorized as previous pregnancies ‘yes’ or ‘no’ and
smoking status was split into three categories: no smoking, smoking
less than 10 cigarettes per day and smoking 10 cigarettes or more
per day.
Statistical analysis
Before the sample sizes were decided, power calculations based
on the following assumption was made: The risk of spontaneous
abortion in DNBC is about 5%. Using 200 cases and 500 non-
cases an odds ratio of 3 could be detected by a power of 80%
(significance level: 0.05).
The strength of the association between spontaneous abortion
and positive serology was expressed as a crude odds ratio. In an
adjusted model we controlled for potential confounding using
logistic regression. Maternal age (,25 years, 25–34 years, 35
years+), gravidity (0, 1+) and smoking during pregnancy (0,
12,10, 10+ cigarettes per day) were a priori selected as potential
confounders.
Lack of interview data on some participants (table 1) resulted in
missing values in the covariates. The missing values were
categorized as a separate category for the variable and adjusted
analyses were carried out for the entire sample. A subsample of
women with complete interview data was also analyzed.
Quantitative analyses on (log transformed) adjusted ELISA OD-
values (optical density values measuring antibody concentrations)
were also done using linear regression.
All analyses were carried out using STATA statistical software,
version 11.
Results
A totalof 218 pregnancies thatended inmiscarriageand 482non-
cases(pregnancieswithnospontaneousabortionsuntil22gestational
weeks)wereincluded. Maternalage wasnormally distributed inboth
groups, but higher in the case group (mean 24.7 years (SD: 9.2) vs.
mean 22.6 years (SD: 9.7) in the control group. Cases were, on
average, recruited at an earlier gestational age than non-cases (8
weeks 5 days (SD2.1) vs. 11 weeks 1 day (SD 3.6)) (Table 1). Among
cases, the median age at abortion was 11.7 weeks (range 6.1 to 20.6
weeks). Three (0.6%) non-cases had delivery before gestational week
32. Furthermore, there were more missing interview data for cases
than non-cases and a higher proportion of cases had prior
pregnancies or were smokers than non-cases (Table 1).
Detection of antibodies by ELISA
In the initial screening, 11 cases (5.05%) and 29 (6.02%) non-
cases were C. burnetii positive in ELISA (crude OR: 0.83) (Table 2).
Confirmation by IFA
One (0.46%) case was confirmed positive in IFA (IgM phase II
positive). For non-cases three (0.62%) were confirmed positive in
IFA (IgM phase II positive, IgG phase II positive and IgM phase I
as well as IgG phase II positive, respectively) (Figure 1).
Altogether, three women had serologic signs of acute infection,
one had signs of a previous infection; none had evident serological
signs of chronic infection.
The prevalence of positive vs. negative Q fever titres in IFA was
not significantly higher in women with spontaneous abortion before
the end of pregnancy week 22 when compared to the control group.
The OR for seropositivity for C.burnetii in pregnancies ending with
miscarriage as compared to control pregnancies was 0.74 (Table 2).
The OR for IFA seropositivity adjusted for a potential
confounding effect of maternal age, previous pregnancies and
smoking was 1.19; (CI: 0.12–11.70) (Table 2). Adjusted odds ratios
were also calculated using the ELISA results. Results for both were
similar to the unadjusted estimates (Table 2). OR’s adjusted for
gestational age at blood sampling were also similar to the
unadjusted estimates (results not shown). In a supplementary
analysis consisting only of women with complete interview data
results remained unchanged (results not shown).
Even though the microimmunofluorescence antibody test (IFA)
was regarded as the gold standard in the analyses, supplementary
analyses were carried out based on the ELISA results alone. In an
age-adjusted, linear regression analysis on adjusted, log-transformed
IgG ELISA OD-values, non-cases had 30% higher OD-values than
cases, (95% CI: 19%–42%); p,0.0005). Controlling for age in the
quantitative comparison did not change the results significantly.
Discussion
To our knowledge, this is the first population based seroepide-
miologic study assessing the association between serologic signs of
Q fever and spontaneous abortion. We hypothesized an
association between serologic signs of Q fever and spontaneous
abortion. Our hypothesis was not confirmed.
Previous case series [11,12] have concluded high risks of
abortions in infected pregnancies. The cases were mainly clinical
with Q fever diagnosed in the French National Reference Centre
for Rickettsial Diseases during pregnancy, and the findings reported
by Raoult et al. could not be reproduced in the present study.
Q Fever and Risk of Spontaneous Abortion
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diagnosed patients in the French case reports may limit their
suitability for assessing the risk of adverse pregnancy outcome
among infected, and may give rise to an overestimation of the
prevalence of complications.
The Netherlands have recently experienced the world’s largest
Q fever outbreak [19] and a new Dutch study examined serum
samples from 1174 pregnancies with a gestational age of 16 weeks
or more from women living in the high-risk area and found no
association between positive Q fever serology and adverse
pregnancy outcome [20]. However, spontaneous abortion was
not the focus of the study.
Outbreaks of Q fever have only been described to occur in small
ruminants. In France, goats and sheep have been the source of
infection and in the recent Dutch outbreak it was goats. Denmark
has never experienced a clinically verified Q fever outbreak and
the source of infection is assumed to be cows. A partial explanation
to the discrepancy in the existing literature might be different
strains of the bacteria with varying virulence and predilection for
small ruminants; but this remains unknown [21].
We regard the use of ELISA as well as IFA in the analyses a
strength in our study.
A variety of serological methods are available; the Panbio
ELISA kit has previously been showed to be superior to other and
suitable for large-scale screening [17,22]. The microimmunofluo-
rescence antibody test (IFA) is regarded as the gold standard [23]
due to the fact that it is capable of determining both phase I and II
antibodies simultaneously by use of two different antigens on the
single sample.
Some countries have defined their own cut-off while others use
the cut-off defined by the manufacturer [18].
The IFA cut-off in Denmark is based on 158 anonymous,
healthy blood donors from three city areas of Denmark assumed
not to have Q fever. Villumsen et al. have chosen a very restrictive
cut-off when defining the local baseline in order to obtain a very
high specificity [18]. The use of different cut-offs or criteria for the
interpretation of serological results hamper the generalisability of
serologic results reported in studies from different countries.
Our supplementary analyses based on ELISA values also
facilitates comparison to other studies that only use ELISA or use a
different IFA cut-off [24].
It is the high positive OD-values in ELISA that are also positive
in IFA which illustrates coherence and supports our choice of
strategy in the analyses; using ELISA as seroepidemiologic
screening with high sensitivity, and regaining specificity in the
confirmatory IFA analyses. The inevitable choices included when
defining a cut-off are avoided when doing analyses based on
quantitative measures, i.e. the quantitative comparison of ELISA
OD-values between cases and non-cases independent of cut-offs
further supports the conclusion of our results and enhances how
analyses based on ELISA values are a useful supplement to
provide additional evidence. However, the quantitative compar-
ison of ELISA OD-values also reveals that the average titer values
among non-cases are significantly higher than among cases.
While this finding may be coincidental, a possible causal
explanation could be that if Q fever is a risk factor for very early
abortion, the exposed participants included in this study constitute
a robust survived population of pregnancies that survived the most
vulnerable period.






,25 22 (10.09%) 69 (14.32%)
252,35 148 (67.89%) 358 (74.27%)
35+ 48 (22.02%) 55 (11.41%)
Missing 0 0
Gestational age at recruitment
,8 weeks 88 (40.37%) 90 (18.67%)
Week 8–12 115 (52.75%) 224 (46.47%)
Week 122,16 13 (5.96%) 118 (24.48%)
Week 16+ 2 (0.92%) 50 (10.37%)
Missing 0 0
Gestational age at abortion (cases), delivery or other pregnancy
outcome* (non-cases)
,Week 8 9 (4.13%)
Week 8–12 107 (49.09%)
Week 122,16 78 (35.78%)
Week 16–22 24 (11.01%) 1 (0.21%)
Week 22–28 2 (0.41%)
Week 28–32 0
Week 32+ 479 (99.38%)
Missing 0 0
Gestational age at blood sampling
,Week 6 27 (12.39%) 40 (8.30%)
Week 6–8 87 (39.10%) 131 (27.18%)
Week 8–10 75 (34.40%) 171 (35.48%)
Week 10–12 25 (11.47%) 90 (18.67%)
Week 12–16 4 (1.83%) 38 (7.88%)
Week 16–28 0 12 (2.49%)
Missing 0 0
Previous pregnancies (N=617)
0 48 (22.02%) 169 (35.06%)
1+ 110 (50.46%) 290 (60.17%)
Missing 60 (27.62%) 23 (4.77%)
Smoking: (N=611)
Non-smokers: 121 (55.5%) 358 (74.27%)
12,10 cigarettes/day 18 (8.26%) 54 (11.2%)
10+ cigarettes/day 19 (8.72%) 41 (8.51%)
Missing 60 (27.52%) 29 (6.02%)
No interview data available: 60 (27.52%) 23 (4.77%)
*Pregnancy outcome: live born singleton, stillbirth, induced abortion after
pregnancy week 12 due to illness in the foetus, live born twins.
doi:10.1371/journal.pone.0031909.t001
Table 2. Crude and adjusted odds ratios for seropositivity for
C.burnetii in pregnancies ending with miscarriage as
compared to control pregnancies.
Crude OR Adjusted* OR 95%CI
ELISA 0.83 0.94 (0.44–2.02)
IFA 0.74 1.19 (0.12–11.70)
*Adjusted for maternal age (with age 252,35 as reference group), gravidity
and smoking.
doi:10.1371/journal.pone.0031909.t002
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resulted in a higher seroprevalence in both groups. However, this
would not have affected our conclusion.
When the IFA results were reported, the confidence intervals
indicate a low precision, and a larger study would be needed to
increase statistical power for detection of smaller effects.
The wide confidence intervals also reflect how the power of the
study was negatively affected by the lower than expected
seroprevalence among women with spontaneous abortion and by
the fact that a sample size of only 218 cases was available.
A recent study used a cohort of Q fever patients to compare
serological and PCR results. Although the same IFA method was
used, there were large discrepancies in the IFA results between
three reference laboratories and the authors proposed develop-
ment of an international standard of Q fever serological
investigation [25].
The discrepancy in the results obtained by different centres
compromises our understanding of the natural course of Q fever in
pregnancy.
Rather than a stand-alone attempt to change previous risk
evaluations, our aim was to perform applicable results and to
contribute to the sparse literature on Q fever and adverse
pregnancy outcome.
This study has some limitations. Due to the gestational age at
enrolment into the cohort, the earliest abortions that constitute the
largest proportion of miscarriages were not included in this study.
Consequently, we cannot exclude a harmful effect of Q fever
infection in very early pregnancy, and furthermore our results may
reflect a ‘healthy pregnant population’ due to the fact that the
pregnancies have successfully survived through the most vulner-
able period. In general, little is known about infections and very
early fetal loss. These very early spontaneous abortions are
insufficiently registered and thus difficult to approach in research.
When studying causes of spontaneous abortions, adjustment for
previous miscarriages is controversial [26]. This is why we chose
adjustment for prior pregnancies, regardless of pregnancy
outcome. Age is an important factor determining miscarriage
risk; adjustment for smoking was justified by the inconsistency of
previous findings related to smoking and spontaneous abortion
[26].
Decline of especially IgM antibodies could also be a limitation
in this study since inclusion of this sample took place between June
1997 and September 2002. However, the four IgM antibody titres
positive in ELISA are distributed between Dec 1997 and Feb 2002
and the 36 IgG antibody titres positive in ELISA between Aug 97
and June 02; an Irish study used 20 years old blood samples to
evaluate the seroprevalence of IgG phase II antibodies [27].
In conclusion, no association between elevated antibody titres
against C.burnetii and spontaneous abortion after gestational week 8
was found.
The aetiology of spontaneous abortions remains largely
unknown with one third of implanted conceptions failing to
survive beyond midpregnancy [26]. Some infections are known to
increase the risk of spontaneous abortions, but the role of the
specific pathogens has been difficult to demonstrate [28]. The size
of this study and the fact that very early spontaneous abortions are
Figure 1. Serologic results: ELISA (using the manufacturer’s cut-off) and IFA (using the Danish cut-off) among cases and non-cases.
Only assays positive in ELISA were reanalyzed using IFA.
doi:10.1371/journal.pone.0031909.g001
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infection and risk of early fetal loss.
However, our results suggest that spontaneous abortion
associated with C.burnetii should not be of great concern among
pregnant women.
Regarding directions for future research into C. burnetii and
spontaneous abortion it would be relevant to study adverse
pregnancy outcome in a pregnant population with high-exposed
women like veterinarians and female workers with contact to
livestock.
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